Hyperglycemia promotes the perineural invasion in pancreatic cancer

Medical Hypotheses

Volumn 71, Issue 3, 2008, Pages 386-389

  Li, Junhui ^a   Ma, Qingyong ^a  

^a First Affiliated Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; NERVE GROWTH FACTOR;

ARTICLE; CANCER CELL; CELL INTERACTION; CELL PROLIFERATION; DEMYELINATION; DISEASE ASSOCIATION; HYPERGLYCEMIA; NERVE DEGENERATION; NERVE FIBER; NERVE REGENERATION; NEUROTROPISM; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION;

HUMANS; HYPERGLYCEMIA; NEOPLASM INVASIVENESS; PANCREAS; PANCREATIC NEOPLASMS; PERIPHERAL NERVOUS SYSTEM NEOPLASMS;

EID: 47549088809     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2008.05.001     Document Type: Article

References (41)

1. Boring C.C., Squires T.S., and Tong T. Cancer statistics. CA Cancer J Clin 43 1 (1993) 7-26
2. Niederhuber J.E., Brennan M.F., and Menck H.R. The National Cancer Data Base report on pancreatic cancer. Cancer 76 (1995) 1671-1677
3. Cooperman A.M. Pancreatic cancer: the bigger picture. Surg Clin North Am 81 (2001) 557-574
4. Hirai I., Kimura W., Ozawa K., et al. Perineural invasion in pancreatic cancer. Pancreas 24 (2002) 15-25
5. Nakao A., Harada A., Nonami T., Kaneko T., and Takagi H. Clinical significance of carcinoma invasion of the extrapancreatic nerve plexus in pancreatic cancer. Pancreas 12 (1996) 357-361
6. Ohyama R. Clinicopathological studies on carcinoma of the pancreas with special reference to pathological factors affecting the prognosis and lymph node involvement. Nippon Geka Gakkai Zasshi 85 (1984) 820-834
7. Nagakawa T., Konishi I., Ueno K., Ohta T., and Kayahara M. A clinical study on lymphatic flow in carcinoma of the pancreatic head area-peripancreatic regional lymph node grouping. Hepatogastroenterology 40 (1993) 457-462
8. Nakai T., Koh K., Kawabe T., Son E., Yoshikawa H., and Yasutomi M. Importance of microperineural invasion as a prognostic factor in ampullary carcinoma. Br J Surg 84 10 (1997) 1399-1401
9. Kayahara M., Nakagawara H., Kitagawa H., and Ohta T. The nature of neural invasion by pancreatic cancer. Pancreas 35 3 (2007) 218-223
10. Pour P.M., Bell R.H., and Batra S.K. Neural invasion in the staging of pancreatic cancer. Pancreas 26 4 (2003) 322-325
11. Bockman D.E. Nerves in the pancreas: what are they for?. Am J Surg 194 4 (2007) 84-86
12. Yi S.Q., Miwa K., Ohta T., et al. Innervation of the pancreas from the perspective of perineural invasion of pancreatic cancer. Pancreas 27 3 (2003) 225-229
13. Nagakawa T., Kayahara M., Ueno K., Ohta T., Konishi I., and Miyazaki I. Clinicopathological study on neural invasion to the extrapancreatic nerve plexus in pancreatic cancer. Hepatogastroenterology 39 1 (1992) 51-55
14. Liu B., and Lu K.Y. Neural invasion in pancreatic carcinoma. Hepatobiliary Pancreat Dis Int 1 3 (2002) 469-476
15. Kenmotsu M., Gochi A., Ishii H., et al. Relationship between perineural invasion and local recurrence of rectal carcinoma: a preliminary study with immunohistochemical staining with anti-NCAM: preliminary report. Nippon Geka Gakkai Zasshi 91 11 (1990) 1759-1763
16. Zhu Z.W., Friess H., Wang L., et al. Nerve growth factor exerts differential effects on the growth of human pancreatic cancer cells. Clin Cancer Res 7 1 (2001) 105-112
17. Zhu Z., Kleeff J., Kayed H., et al. Nerve growth factor and enhancement of proliferation, invasion, and tumorigenicity of pancreatic cancer cells. Mol Carcinog 35 3 (2002) 138-147
18. Hua Z.M., Li Z., and Lou D.L. Relation of nerve growth factor expression with perineural invasion and pain in pancreatic cancer. Nan Fang Yi Ke Da Xue Xue Bao 26 8 (2006) 1251-1253
19. Chari S.T., Leibson C.L., Rabe K.G., et al. Pancreatic cancer-associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer. Gastroenterology 134 (2008) 95-101
20. Krechler T., Novotný J., Zeman M., et al. Pancreatic carcinoma and diabetes mellitus. Cas Lek Cesk 143 2 (2004) 97-100
21. Saruc M., and Pour P.M. Diabetes and its relationship to pancreatic carcinoma. Pancreas 26 4 (2003) 381-387
22. Wang F., Herrington M., Larsson J., and Permert J. The relationship between diabetes and pancreatic cancer. Mol Cancer 2 (2003) 4
23. Gupta S., Vittinghoff E., Bertenthal D., et al. New-onset diabetes and pancreatic cancer. Clin Gastroenterol Hepatol 4 11 (2006) 1366-1372
24. Katsumichi I., and Pour P.M. Diabetes mellitus in pancreatic cancer: is it a causal relationship?. Am J Surg 194 4 (2007) S71-S75
25. Tomlinson D.R., and Gardiner N.J. Glucose neurotoxicity. Nat Rev Neurosci 9 1 (2008) 36-45
26. Zochodne D.W. Diabetes mellitus and the peripheral nervous system: manifestations and mechanisms. Muscle Nerve 36 2 (2007) 144-166
27. Malik R.A., Tesfaye S., Newrick P.G., et al. Sural nerve pathology in diabetic patients with minimal but progressive neuropathy. Diabetologia 48 (2005) 578-585
28. Boucek P. Advanced diabetic neuropathy: a point of no return?. Rev Diabet Stud 3 3 (2006) 143-150
29. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 414 (2001) 813-820
30. Busik J.V., Hootman S.R., Greenidge C.A., and Henry D.N. Glucose specific regulation of aldose reductase in capan-1 human pancreatic duct cells in vitro. J Clin Invest 100 (1997) 1685-1692
31. Giovannucci E., and Michaud D. The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas. Gastroenterology 132 6 (2007) 2208-2225
32. Suba Z., and Ujpál M. Correlations of insulin resistance and neoplasms. Magy Onkol 50 2 (2006) 127-135
33. Dombrowski F., Klotz L., Bannasch P., and Evert M. Renal carcinogenesis in models of diabetes in rats: metabolic changes are closely related to neoplastic development. Diabetologia 50 12 (2007) 2580-2590
34. Talamini R., Franceschi S., Favero A., Negri E., Parazzini F., and La Vecchia C. Selected medical conditions and risk of breast cancer. Br J Cancer 75 11 (1997) 1699-1703
35. La Vecchia C., Negri E., Franceschi S., D'Avanzo B., and Boyle P. A case-control study of diabetes mellitus and cancer risk. Br J Cancer 70 5 (1994) 950-953
36. Weiderpass E., Gridley G., Persson I., Nyrén O., Ekbom A., and Adami H.O. Risk of endometrial and breast cancer in patients with diabetes mellitus. Int J Cancer 71 3 (1997) 360-363
37. Goodman M.T., Cologne J.B., Moriwaki H., Vaeth M., and Mabuchi K. Risk factors for primary breast cancer in Japan: 8-year follow-up of atomic bomb survivors. Prev Med 26 1 (1997) 144-153
38. Fisher W.E., McCullough P.J., Ray M.B., Rogers D.H., and Bell R.H. Diabetes enhances growth of pancreatic carcinoma cells. Surgery 104 (1988) 431-436
39. Fisher W.E., Muscarella P., Boros L.G., and Schirmer W.J. Variable effect of streptozotocin-diabetes on the growth of hamster pancreatic cancer (H2T) in the Syrian hamster and nude mouse. Surgery 123 3 (1998) 315-320
40. Okumura M., Yamamoto M., Sakuma H., et al. Leptin and high glucose stimulate cell proliferation in MCF-7 human breast cancer cells: reciprocal involvement of PKC-alpha and PPAR expression. Biochim Biophys Acta 1592 2 (2002) 107-116
41. Krone C.A., and Ely J.T. Controlling hyperglycemia as an adjunct to cancer therapy. Integr Cancer Ther 4 1 (2005) 25-31